A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer

BACKGROUND: Endostatin inhibits the pro-angiogenic action of basic fibroblast growth factor and vascular endothelial growth factor in different human cancers. This study assessed the efficacy of endostatin combined with concurrent chemoradiotherapy of non-small cell lung cancer (NSCLC). METHODS: Nin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiao-Jiang, Deng, Qing-Hua, Yu, Xin-Min, Ji, Yong-Lin, Zheng, Yuan-Da, Jiang, Hao, Xu, Ya-Ping, Ma, Sheng-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828797/
https://www.ncbi.nlm.nih.gov/pubmed/27067521
http://dx.doi.org/10.1186/s12885-016-2234-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828797/
https://www.ncbi.nlm.nih.gov/pubmed/27067521
http://dx.doi.org/10.1186/s12885-016-2234-0

Ejemplares similares